Abstract:Objective To explore the VEGF,Flt-1 and KDR mRNA and protein expression in primary gallbladder carcinoma (PGC) and their correlation with primary gallbladder carcinoma clinicopathological characteristics.Methods The VEGF,Flt-1 and KDR mRNA and protein expression in the fresh resected samples of 21 cases of primary gallbladder carcinoma and 10 cases of gallbladder adenomaous ployps (GAP) was deteched by RT-PCR and immunohistochemistry.The correlation between VEGF,Flt-1 and KDR protein positive expression in PGC and the clinicopathological characteristics of PGC was analysed as well.Results The VEGF mRNA positive expression rates in all PGC and GAP cases were 90.47% (19/21) and 20% (2/10),the Flt-1 mRNA positive expression rates were 71.42% (15/21) and 0 (0/10) and the KDR mRNA positive expression rates were 85.71% (18/21) and 10% (1/10),respectively,with the difference being significant between PGC cases and GAP cases (P 0.05).The VEGF protein positive expression rates of all PGC and GAP cases were 80.95% (17/21) and 20% (2/10),the Flt-1 protein positive expression rates were 60.90% (13/21) and 10% (1/10) and the KDR protein positive expression rates were 76.19% (16/21) and 10% (1/10),respectively,with the difference being significant between two groups (P 0.05).The VEGF,Flt-1 and KDR protein positive expression rates in PGC cases with liver infiltration,lymphatic metastasis and Nevin IV and V stages were significantly higher than those in the cases withou liver infiltration,lymphatic metastasis and Nevin I,Ⅱ and Ⅲ stages of PGC (P 0.05).However,the positive expression rates of VEGF,Flt-1[BG)W][LM][BG(][BHDWG8*2,WK42ZQ0W] and KDR protein had no difference among the high,middle and low differentiation of PGC cases (P 0.05).Conclusion The VEGF,Flt-1 and KDR mRNA and protein were all overexpressed in the cases of PGC and the overexpressions of VEGF,Flt-1 and KDR protein were significantly correlated with PGC liver infiltration,lymphatic metastasis and Nevin IV and V stages,but not with the PGC pathological differentiation.

Expression of LRP and Topoll in Gallbladder Carcinoma and Cholangiocarcinoma

Expression of multidrug resistance-related proteins MRP1/MRP2/LRP/Topo Ⅱ/GST-π in carcinoma of callbladder and cholangiocarcinoma

Expression of ToPo Ⅱ,MRP,GST-π in Gastric Carcinoma and Its Relationship with Prognosis

Expression of multidrug resistance-related proteins MRP1/MRP2/LRP/Topo II/GST-π in carcinoma of callbladder and cholangiocarcinoma

Effect of Lung Resistance-Related Protein on the Resistance to Cisplatin in Human Ovarian Cancer Cell Lines.

NDRG2 Expression and Mutation in Human Liver and Pancreatic Cancers

Expressions and Significances of Topoisomeraseⅱ and Multidrug Resistance-Associated Protein in Human Esophageal Squamous Cell Carcinoma

Expression of Topo IIα and P-glycoprotein in Gallbladder Carcinoma and Their Clinical Significance

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

Expression of Multidrug Resistance-Related Proteins MRP1/LRP/GST-π in Carcinoma of the Gallbladder and Cholangiocarcinoma

Influence of Neoadjuvant Chemotherapy on the Expression of Drug Resistance Genes in Breast Carcinoma

Expression And Significance Of Glucose Transporter-1, P-Glycoprotein, Multidrug Resistance-Associated Protein And Glutathione S-Transferase-Pi In Laryngeal Carcinoma

Expression and Clinical Significance of Lung Resistance Protein, P- Giycoprotein, Glutathione-S-transferase-π and Topoisomeraseii in Lung Cancer

Protein Expression and Correlation with Prognosis of Three Drug Resistant Genes in Human Breast Carcinoma

Significance Of Multidrug Resistance Gene-Related Proteins In The Postoperative Chemotherapy Of Gastric Cancer

Expression and Implication of P-gp and Topo-II in Hepatocellular Carcinoma

The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer

Effect of Multidrug-Resistant-proteins in Neoadjuvant Chemotherapy in Patients with Breast Cancer

Multidrug Resistance Protein and Topoisomerase 2 Alpha Expression in Non-Small Cell Lung Cancer Are Related with Brain Metastasis Postoperatively.

Expression of Multi-Drug Resistance-Related Genes MDR3 and MRP As Prognostic Factors in Clinical Liver Cancer Patients.

Drug Susceptibility Test in Carcinoma of Gallbladder and Cholangiocarcinoma